X

Abbott Laboratories (ABT) Earnings: 1Q21 Key Numbers

Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today.

Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis, sales growth was 32.9%.

On a GAAP basis, net earnings more than doubled to $1.79 billion, or $1.00 per share, compared to the year-ago period. Adjusted EPS jumped 103% to $1.32.

For FY2021, Abbott projects GAAP EPS from continuing operations to be at least $3.74. Adjusted EPS from continuing operations is expected to be at least $5.00.

Related Post